• VX-765: Unlocking Caspase-1’s Role in Inflammation and Cell

  2026-07-01

  Discover how VX-765, a potent and selective caspase-1 inhibitor, is transforming translational research in inflammation and cell death. This article delivers mechanistic insight, strategic guidance, and critical protocol considerations for leveraging VX-765 in preclinical and translational workflows, with a focus on evidence integration and practical recommendations for maximizing impact.

• Eicosapentaenoic Acid: Redefining Translational Cardiovascul

  2026-06-30

  This thought-leadership article explores how Eicosapentaenoic Acid (EPA), an omega-3 polyunsaturated fatty acid, is transforming cardiovascular and immune research. We synthesize mechanistic insights, protocol guidance, and recent advances—including prostaglandin-mediated immune modulation—while offering strategic perspectives for translational researchers leveraging high-purity EPA from APExBIO.

• Aconitase Assays Redefine Metabolic Flexibility in Immunolog

  2026-06-30

  This thought-leadership article explores how colorimetric aconitase activity assays, such as the Aconitase Activity Colorimetric Assay Kit from APExBIO, are transforming translational research in immunometabolism. By bridging precision enzyme detection with recent advances in T cell metabolic reprogramming, we guide researchers through the mechanistic underpinnings, experimental strategies, and future potential of integrating iron-sulfur protein aconitase measurements into studies of oxidative stress, mitochondrial function, and antitumor immunity.

• Norovirus Utilizes NINJ1 for Selective Secretion of NS1 Prot

  2026-06-29

  Song et al. reveal that murine norovirus (MNoV) hijacks the host plasma membrane protein NINJ1 to selectively secrete the viral immune antagonist NS1, while simultaneously releasing cellular DAMPs. Through genetic and biochemical approaches, the study establishes NINJ1 as a key regulator of unconventional protein secretion during viral infection, offering new insight into host-pathogen interactions.

• Dual-Action p38α MAPK Inhibitors: Mechanisms of Dephosphoryl

  2026-06-29

  Recent work reveals that certain p38α MAPK inhibitors not only block kinase activity but also accelerate dephosphorylation by stabilizing the kinase in a phosphatase-accessible conformation. This mechanistic insight paves the way for more precise modulation of inflammatory signaling and informs the development of next-generation kinase inhibitors for disease modeling.

• Ciprofloxacin Potentiates Ferroptosis via Mitochondrial Zinc

  2026-06-28

  This study uncovers how ciprofloxacin enhances RSL3-induced ferroptosis in cancer cells by promoting mitochondrial Zn²⁺ accumulation through activation of the STING1–CAV2 pathway. These findings reveal a dual, context-dependent role for ciprofloxacin in ferroptosis regulation, with potential implications for targeted cancer therapies.

• NSC23766 Trihydrochloride: Selective Rac1 GTPase Inhibitor I

  2026-06-27

  NSC23766 trihydrochloride is a selective Rac GTPase inhibitor that disrupts Rac1-GEF interactions, modulating cellular processes central to cancer research. Its efficacy and selectivity are evidenced in both in vitro and in vivo models, with well-documented benchmarks for apoptosis induction and cell cycle arrest. This article synthesizes recent findings, practical workflows, and limitations for researchers.

• T-5224 (C-Fos/AP-1 Inhibitor): Mechanisms, Innovations, and

  2026-06-26

  Explore the advanced molecular mechanisms and translational significance of T-5224, a selective C-Fos/AP-1 inhibitor. This article unveils recent discoveries in ferroptosis, arthritis research, and inflammation modulation, providing unique guidance for experimental design.

• InstaBlue Protein Stain Solution: Rapid, Sensitive Gel Visua

  2026-06-26

  InstaBlue Protein Stain Solution redefines protein gel workflows with instant, high-sensitivity visualization—ideal for demanding biomedical research and mass spectrometry applications. Its unique, non-toxic formula streamlines experimental timelines and preserves protein integrity, enabling advanced studies like those dissecting molecular dysfunction in neurodegenerative disease.

• JNK-IN-7: Selective JNK Inhibitor for Advanced Apoptosis Ass

  2026-06-25

  JNK-IN-7 unlocks highly selective, covalent modulation of JNK signaling, enabling researchers to dissect MAPK-driven apoptosis and innate immune mechanisms with unprecedented precision. Learn how to optimize workflows and troubleshoot common pitfalls when applying JNK-IN-7 to cell-based kinase and immune response assays.

• Inflammation in Ischemic Stroke: Biomarkers and Treatment Ad

  2026-06-25

  Xiao et al. (2025) provide a comprehensive synthesis of the inflammatory mechanisms underlying ischemic stroke, with an emphasis on diagnostic biomarkers and therapeutic strategies. Their review bridges fragmented insights, guiding clinicians and researchers toward more precise and multifaceted interventions.

• Practical Use of HyperScribe™ T7 High Yield Cy3 RNA Labeling

  2026-06-24

  The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus addresses the need for efficient, reproducible synthesis of fluorescently labeled RNA probes for in situ hybridization and Northern blotting. It is intended exclusively for research use and should not be applied in diagnostic or clinical workflows.

• BMAL1 Phase Separation Drives Circadian Transcriptional Hubs

  2026-06-23

  Gao et al. reveal that BMAL1, a core circadian clock protein, forms phase-separated nuclear condensates that act as dynamic transcriptional hubs, regulated by an intrinsically disordered region and its phosphorylation state. This mechanistic insight clarifies how BMAL1 precisely times circadian gene expression, providing new directions for the study of post-translational modifications in circadian biology.

• OSMI-1: Transforming O-GlcNAcylation Research in Preeclampsi

  2026-06-23

  This thought-leadership article explores how OSMI-1, a potent O-GlcNAc transferase inhibitor from APExBIO, is revolutionizing translational research into ferroptosis and trophoblast syncytialization, with an emphasis on preeclampsia. Drawing on recent mechanistic breakthroughs, we synthesize biological rationale, experimental strategies, and practical protocol guidance for researchers aiming to dissect the O-GlcNAc-HUWE1-TfR1 axis. The article contextualizes OSMI-1’s value versus the competitive landscape and projects future directions in placental biology.

• HyperScribe T7 Cy5 RNA Labeling Kit: Precision for Modern RN

  2026-06-22

  Explore how the HyperScribe T7 High Yield Cy5 RNA Labeling Kit advances in situ hybridization probe preparation with unprecedented yield and flexibility. This article reveals unique mechanistic insights and strategic assay considerations for researchers seeking next-generation fluorescent RNA labeling.

454 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page